Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about how the “Federal Circuit on Friday appeared unlikely to overturn an injunction removing from the market a NeoGenomics Laboratories Inc. cancer screening test due to a pair of Natera Inc. patents”;
- an article highlighting a Federal Circuit ruling that, “though marked non-precedential, arguably expands the application of the abstract idea exception to patentability under 35 U.S.C. §101 for blockchain technologies even when those patents are claiming the use of specialized, non-generic computer hardware”; and
- an article discussing the Federal Circuit’s holding “that a California federal judge wasn’t wrong to deny an injunction request after declaring that a ‘substantial question of validity’ had been raised over a patent covering a way of testing the durability of a heart valve.”